The price of this share is at 20,34$, Veracyte Inc, with address at 6000 SHORELINE COURT SUITE 300, SOUTH SAN FRANCISCO, California, 94080, United States, is a publicly traded company and its visible heads at the moment are Giulia C. Kennedy (Chief Scientific & Medical Officer), Marc A. Stapley (Chief Executive Officer & Director), Rebecca Chambers (Chief Financial Officer), Richard T. Kloos (Executive Medical Director), Robert Brainin (Chief Business Officer & Executive Vice President). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 19,98$ moving between 19,58$ and 20,37$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
